BridgeBio Pharma Inc logo

BBIO - BridgeBio Pharma Inc News Story

$54.13 0.5  0.9%

Last Trade - 17/05/21

Sector
Healthcare
Size
Large Cap
Market Cap £5.72bn
Enterprise Value £6.04bn
Revenue £6.16m
Position in Universe 1058th / 6846

BRIEF-BridgeBio Pharma Collaborates With Roswell Park To Advance Development Of Therapeutics For Genetically Driven Cancers

Tue 13th April, 2021 3:01pm
April 13 (Reuters) - BridgeBio Pharma Inc  BBIO.O :
    * BRIDGEBIO PHARMA - COLLABORATING WITH ROSWELL PARK TO
ADVANCE
DEVELOPMENT OF INVESTIGATIONAL THERAPEUTICS FOR PATIENTS WITH
GENETICALLY DRIVEN CANCERS

Source text for Eikon:  ID:nGNX9MGzBS 
Further company coverage:  BBIO.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.